IQVIA Holdings Inc
NYSE:IQV
IQVIA Holdings Inc
EPS (Diluted)
IQVIA Holdings Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
72%
|
CAGR 5-Years
43%
|
CAGR 10-Years
16%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$15
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$10
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
EPS (Diluted)
$7
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
EPS (Diluted)
$36
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
See Also
What is IQVIA Holdings Inc's EPS (Diluted)?
EPS (Diluted)
7.3
USD
Based on the financial report for Dec 31, 2023, IQVIA Holdings Inc's EPS (Diluted) amounts to 7.3 USD.
What is IQVIA Holdings Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
16%
Over the last year, the EPS (Diluted) growth was 27%. The average annual EPS (Diluted) growth rates for IQVIA Holdings Inc have been 72% over the past three years , 43% over the past five years , and 16% over the past ten years .